Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-030-58174-9_5
Reference73 articles.
1. Benezra, M., Penate-Medina, O., Zanzonico, P. B., Schaer, D., Ow, H., Burns, A., et al. (2011). Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. The Journal of Clinical Investigation, 121(7), 2768–2780.
2. Chen, F., Goel, S., Shi, S., Barnhart, T. E., Lan, X., & Cai, W. (2018). General synthesis of silica-based yolk/shell hybrid nanomaterials and in vivo tumor vasculature targeting. Nano Research, 11(9), 4890–4904.
3. Choi, Y. H., & Han, H. K. (2018). Nanomedicines: Current status and future perspectives in aspect of drug delivery and pharmacokinetics. Journal of Pharmaceutical Investigation, 48(1), 43–60.
4. Huang, M., Liu, L., Wang, S., Zhu, H., Wu, D., Yu, Z., et al. (2017). Dendritic mesoporous silica nanospheres synthesized by a novel dual-templating micelle system for the preparation of functional nanomaterials. Langmuir, 33(2), 519–526.
5. Zhan, Z., Zhang, X., Huang, J., Huang, Y., Huang, Z., Pan, X., et al. (2017). Improved gene transfer with functionalized hollow mesoporous silica nanoparticles of reduced cytotoxicity. Materials (Basel), 10(7), 731.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Engineering Matrix-Free Drug Protein Nanoparticles with Promising Penetration through Biobarriers for Treating Corneal Neovascularization;ACS Nano;2024-03-07
2. Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics;Cancer Nanotechnology;2024-01-31
3. Validation of Dual-Action Chemo-Radio-Labeled Nanocarriers with High Efficacy against Triple-Negative Breast Cancer;ACS Applied Materials & Interfaces;2023-10-13
4. Nano Differential Scanning Fluorimetry as a Rapid Stability Assessment Tool in the Nanoformulation of Proteins;Pharmaceutics;2023-05-11
5. Constructing a drug release model by central composite design to investigate the interaction between drugs and temperature-sensitive controlled release nanoparticles;European Journal of Pharmaceutics and Biopharmaceutics;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3